Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113234696A reveals high-purity in vitro crocetin production. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112437813A reveals a one-step enzymatic NAD synthesis. This method significantly lowers production costs and simplifies supply chains for global buyers.
Novel enzymatic method for L-glufosinate-ammonium production eliminates coenzyme regeneration costs. Reliable supplier for high-purity agrochemical intermediates with scalable green manufacturing.
Novel plant-derived synthesis route for Ursodeoxycholic Acid ensures high purity and supply continuity. Ideal for pharmaceutical intermediates manufacturing.
Patent CN1087350C reveals a breakthrough enzymatic method for beta-lactam antibiotics, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN1782088A details enzymatic resolution for high-purity tryptophan 15N. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN104293867A details high-yield enzymatic route for 2'-Deoxy-5-Fluorouridine offering scalable production and significant cost efficiency for global supply chains.
Patent CN116287086B reveals enzymatic water-phase synthesis for tazobactam. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Patent CN110272839A enables high-purity chiral acid synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN110106130B details a robust transaminase-PLP co-immobilized cell method for sitagliptin intermediates, offering superior stability and cost efficiency for pharmaceutical supply chains.
Patent CN115927507A reveals a novel enzymatic route for oligosaccharides. Achieve significant cost reduction in pharmaceutical intermediates manufacturing via ATP regeneration.
Patent CN110551781A reveals high-yield enzymatic route for 5'-GMP. Discover cost reduction and supply chain advantages for industrial manufacturing.
Patent CN102656274B details anaerobic enzymatic synthesis reducing impurities. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN120944982A reveals high-yield ergothioneine production. Discover cost reduction in nutritional ingredients manufacturing and supply chain reliability.
Patent CN114667346A reveals novel EanB mutants for ergothioneine production. Discover cost-effective enzymatic routes replacing slow fungal fermentation for reliable supply.
Patent CN1260364C reveals a novel enzymatic hydrolysis using bulky esters for high-purity beta-amino acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113881728B reveals a chemo-enzymatic route for PreQ 1, enhancing yield and reducing waste for pharmaceutical intermediate manufacturing supply chains.
Novel enzymatic method for loxoprofen resolution offers high purity and green manufacturing advantages for pharmaceutical supply chains seeking reliable intermediate partners.
Patent CN111321176A reveals a lipase-catalyzed route for high-purity 4-octyl itaconate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105543201B details a mutant enzyme boosting 7-ACA yield. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier solutions.